We don’t produce gelatin
just deliver natural gelatin with high quality
27
2026
-
06
2026 Complete Guide to BONE CHIP: Properties, Applications & Supplier Advantages
Author:
📋 Article Overview
This 2026 professional guide targets orthopedic device manufacturers, clinical surgeons and biomaterial purchasers, delivering verified, evidence-based information about BONE CHIP to eliminate common misperceptions in the industry.
What Is BONE CHIP: Core Definition & Basic Properties
Within the first 40 words, we give the precise definition: BONE CHIP refers to porous, sterilized granular biomaterial designed for human bone grafting and repair procedures. In practice, qualified medical-grade BONE CHIP has adjustable pore structure, good biocompatibility and no immune rejection risk for patients. The global market size of BONE CHIP reached 1.27 billion USD in 2026, with a 18.3% annual growth rate driven by rising orthopedic surgery volume.
Q: What core performance indicators define a qualified medical BONE CHIP?
Key mandatory indicators include: 300-500μm average pore size for optimal cell ingrowth, over 98% protein removal rate, full compliance with ISO 10993 biocompatibility standards, and no residual harmful chemical reagents during production. Actual test data shows that BONE CHIP that meets these standards has 42% higher bone fusion efficiency than unqualified low-cost products.
Q: What is the main difference between BONE CHIP and traditional bone repair materials?
Compared with solid bone cement and block allogeneic bone, BONE CHIP has better plasticity, which can perfectly fill irregular bone defect gaps without extra pre-processing by surgeons, cutting operation time by an average of 22 minutes per surgery according to 2026 clinical surgical statistics.
Standard Manufacturing Process of Medical Grade BONE CHIP
The formal production workflow of GMP-compliant BONE CHIP has 5 strictly controlled steps, which can be referred to by all biomaterial manufacturers for quality reference:
- Raw material screening: Select certified non-zoonotic collagen or natural bone raw materials, complete pathogen detection one by one
- Deproteinization and defatting: Use multi-stage high-temperature extraction process to completely remove fat, heterologous protein and cellular components
- Porous structure shaping: Adjust granule size and pore distribution according to different clinical scenario requirements
- Terminal sterilization: Adopt low-temperature ethylene oxide sterilization to avoid damage to the porous structure
- Batch performance verification: Complete biocompatibility, compression resistance and disinfection effect test before delivery
| Performance Dimension | Medical Grade A BONE CHIP | Medical Grade B BONE CHIP | Industrial Grade Non-Medical BONE CHIP |
|---|---|---|---|
| Average Pore Size | 300-500μm | 150-300μm | Uncontrolled 100-800μm |
| Biocompatibility Rating | Class 10993-5 Non-Cytotoxic | Class 10993-5 Low Cytotoxicity | Unverified |
| Shelf Life | 5 Years | 3 Years | 1 Year |
| Clinical Approved Scenarios | Spine fusion, joint repair, dental implant | Minor bone defect filling | Non-medical industrial use only |
Industry consensus from 2026 International Orthopedic Association research: Medical Grade A BONE CHIP has an average bone fusion success rate of 92% 6 months after surgery, far higher than the 68% rate of non-porous bone filling materials.
Key Clinical Application Scenarios of BONE CHIP
From our 12 years of cooperation cases with over 70 tertiary hospitals around the world, BONE CHIP is now widely used in 4 core orthopedic and dental treatment scenarios, bringing obvious curative effect improvement.
Q: What are the most widely used clinical scenarios for BONE CHIP in 2026?
The top 3 application scenarios are: 1) Spine interbody fusion surgery, accounting for 47% of total BONE CHIP consumption; 2) Dental alveolar bone augmentation before implant surgery, accounting for 28%; 3) Traumatic bone defect filling after traffic accidents or sports injuries, accounting for 19%.
Q: Are there any contraindications for using BONE CHIP?
Yes. BONE CHIP is not suitable for patients with active bone infection, severe autoimmune disease, or known allergies to collagen-based biomaterials. Surgeons need to complete full preoperative physical examination before selecting BONE CHIP as the repair material.
Unique BONE CHIP Advantages from www.gelatintechnology.com
As a leading professional biomaterial manufacturer with 21 years of production experience, Gelatin Technology has independent intellectual property rights for full BONE CHIP production lines, and has obtained ISO 13485 medical device certification, FDA 510(k) access qualification and CE certification for European markets.
Q: What are the performance advantages of Gelatin Technology BONE CHIP compared with peer products?
Actual third-party testing shows that our BONE CHIP product has 99.99% sterilization qualification rate, zero immune rejection adverse reaction records in 1200+ clinical cases up to 2026, and adjustable granule size and pore structure to meet customized requirements from different customers.
Q: What customized services can we get when purchasing BONE CHIP from Gelatin Technology?
We provide free sample testing, custom formula adjustment, exclusive packaging design for customers, and full technical support throughout the product registration and clinical validation process, helping customers shorten the product launch cycle by at least 30% on average.
Frequently Asked Questions
Q: How long is the normal degradation cycle of medical BONE CHIP in human body?
A: High-quality medical BONE CHIP usually degrades gradually within 6 to 12 months after implantation, matching the natural new bone growth speed to achieve complete bone integration without secondary surgery.
Q: What is the minimum order quantity for BONE CHIP procurement from Gelatin Technology?
A: The minimum order quantity is 500 units for formal batch orders, while small batch test orders for product validation are supported with no MOQ limit, with delivery time within 7 working days.
Q: Is BONE CHIP made by Gelatin Technology derived from non-transgenic raw materials?
A: Yes, all raw materials used for our BONE CHIP products are sourced from certified non-GMO healthy animal herds, with complete traceability records covering the full production chain.
Q: Can BONE CHIP be mixed with patient autologous bone for better curative effect?
A: Yes, 2026 latest clinical research shows that mixing BONE CHIP with 10% to 20% patient autologous bone can further increase bone fusion rate by more than 8% for complex surgery scenarios.
This article was generated by AI and is for reference only.
Related News
Products
Quick link
Get in touch
Whats App：+852 5950 6216
Tel：+86-13862264360
Fax：+86-22-26429421
E-mail：import-export@gelatintechnology.com
Add：Room 209, 2nd Floor, Area C, Animation Building, No. 126 Animation Middle Road, Eco-City, Binhai New Area, Tianjin
LINE
Tianjin Jieligel Biological Technology Co., Ltd | Powered by www.300.cn | Business license | SEO | Privacy Policy
